NASDAQ:ESTA

Establishment Labs Stock Forecast, Price & News

$72.38

-3.50 (-4.61 %)

(As of 07/27/2021 04:30 PM ET)

Add

Compare

Today's Range

$70.88

▼

$75.56

50-Day Range

$72.20

▼

$88.21

52-Week Range

$15.73

▼

$88.66

Volume114,816 shs

Average Volume105,339 shs

Market Capitalization$1.71 billion

P/E RatioN/A

Dividend YieldN/A

Beta1.09

30 days | 90 days | 365 days | Advanced Chart

Receive ESTA News and Ratings via Email

Sign-up to receive the latest news and ratings for Establishment Labs and its competitors with MarketBeat's FREE daily newsletter.

About Establishment Labs

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand. It also provides Divina 3D surgical simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Establishment Labs earnings: here's what Wall Street expects
July 27, 2021 | markets.businessinsider.com

Establishment Labs (NASDAQ:ESTA) & Surgalign (NASDAQ:SRGA) Critical Analysis
July 27, 2021 | americanbankingnews.com

Establishment Labs Releases 2020 Corporate Social Responsibility Annual Review
July 20, 2021 | finance.yahoo.com

Establishment Labs to Announce Second Quarter 2021 Financial Results on July 29
July 16, 2021 | finance.yahoo.com

Letco Med and Fourth Power Labs Partner to Bring Hemp-Derived, THC-Free CBD Products to Compounding Pharmacies and their Patients
July 15, 2021 | markets.businessinsider.com

Establishment Labs Announces Appointment of Ann Custin and Bryan Slotkin to Board of Directors
July 15, 2021 | finance.yahoo.com

Establishment Labs (NASDAQ:ESTA) Shares Gap Up to $74.30
July 15, 2021 | americanbankingnews.com

Establishment Labs (NASDAQ:ESTA) Shares Gap Down to $83.23
July 13, 2021 | americanbankingnews.com

Establishment Labs Announces Departure of CFO and Appointment of Raj Denhoy as Interim CFO
July 12, 2021 | finance.yahoo.com

Reviewing Ortho Regenerative Technologies (OTCMKTS:ORTIF) and Establishment Labs (NASDAQ:ESTA)
July 11, 2021 | americanbankingnews.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:ESTA
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.establishmentlabs.com
Phone506 2434 2400
Employees638
Year FoundedN/A

Sales & Book Value

Annual Sales$84.68 million
Price / Sales20.25
Cash FlowN/A
Price / Cash FlowN/A
Book Value$3.20 per share
Price / Book22.62

Profitability

EPS (Most Recent Fiscal Year)($1.55)
Net Income$-38,120,000.00
Net Margins-30.17%
Return on Equity-35.32%
Return on Assets-17.61%

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares23,688,000
Market Cap$1.71 billion
Next Earnings Date7/29/2021 (Confirmed)
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.42 out of 5 stars

Medical Sector

1108th out of 2,218 stocks

Surgical Appliances & Supplies Industry

23rd out of 41 stocks

1.5 Analyst's Opinion

Consensus Rating
Establishment Labs has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $63.67, Establishment Labs has a forecasted downside of 11.7% from its current price of $72.13.
Amount of Analyst Coverage
Establishment Labs has only been the subject of 1 research reports in the past 90 days.

3.3 Community Rank

Outperform Votes
Establishment Labs has received 95 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Establishment Labs has received 49 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Establishment Labs has received 65.97% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Establishment Labs and other stocks. Vote “Outperform” if you believe ESTA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ESTA will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Establishment Labs does not currently pay a dividend.
Dividend Growth
Establishment Labs does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Establishment Labs insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,893,358.00 in company stock.
Percentage Held by Insiders
Only 13.08% of the stock of Establishment Labs is held by insiders.
Percentage Held by Institutions
58.39% of the stock of Establishment Labs is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Establishment Labs are expected to grow in the coming year, from ($1.07) to ($0.70) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Establishment Labs is -62.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Establishment Labs is -62.72, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Establishment Labs has a P/B Ratio of 22.54. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Establishment Labs (NASDAQ:ESTA) Frequently Asked Questions

Is Establishment Labs a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Establishment Labs in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Establishment Labs stock.
View analyst ratings for Establishment Labs or view top-rated stocks.

What stocks does MarketBeat like better than Establishment Labs?

Wall Street analysts have given Establishment Labs a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Establishment Labs wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Establishment Labs' next earnings date?

Establishment Labs is scheduled to release its next quarterly earnings announcement on Thursday, July 29th 2021.
View our earnings forecast for Establishment Labs.

How can I listen to Establishment Labs' earnings call?

Establishment Labs will be holding an earnings conference call on Thursday, July 29th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Establishment Labs' earnings last quarter?

Establishment Labs Holdings Inc. (NASDAQ:ESTA) posted its quarterly earnings results on Wednesday, May, 5th. The company reported ($0.29) EPS for the quarter, topping analysts' consensus estimates of ($0.34) by $0.05. The company had revenue of $30.34 million for the quarter, compared to analyst estimates of $25.20 million. Establishment Labs had a negative net margin of 30.17% and a negative trailing twelve-month return on equity of 35.32%.
View Establishment Labs' earnings history.

How has Establishment Labs' stock price been impacted by COVID-19?

Establishment Labs' stock was trading at $15.15 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ESTA stock has increased by 377.8% and is now trading at $72.38.
View which stocks have been most impacted by COVID-19.

What guidance has Establishment Labs issued on next quarter's earnings?

Establishment Labs issued an update on its second quarter 2021 earnings guidance on Monday, July, 26th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $31 million-$32 million, compared to the consensus revenue estimate of $28.92 million.

What price target have analysts set for ESTA?

3 brokerages have issued 12-month price objectives for Establishment Labs' shares. Their forecasts range from $23.00 to $88.00. On average, they anticipate Establishment Labs' share price to reach $63.67 in the next twelve months. This suggests that the stock has a possible downside of 12.0%.
View analysts' price targets for Establishment Labs or view top-rated stocks among Wall Street analysts.

Who are Establishment Labs' key executives?

Establishment Labs' management team includes the following people:

Mr. Juan Jose Chacon Quiros, Founder, CEO & Exec. Director (Age 49, Pay $598.16k)
Ms. Renee M. Gaeta, Chief Financial Officer (Age 40, Pay $480.39k)
Mr. Salvador Santos Dada, Chief Operating Officer (Medical Leave of Absence) (Age 38, Pay $468.62k)
Mr. Pratip Dastidar, Head of Global Operations (Age 58)
Mr. Roberto De Mezerville, Chief Technology Officer (Age 41)
David K. Erickson, VP of Investor Relations
Mr. Rajbir Singh Denhoy, Head of Strategy & Investor Relations
Ms. Neeta Toprani, Gen. Counsel & Corp. Sec.
Dr. Heather Brennan, Head of U.S. Commercial Operations
Mr. Eddie De Oliveira, VP of Sales, Brazil (Age 39)

Who are some of Establishment Labs' key competitors?

Some companies that are related to Establishment Labs include MSA Safety (MSA), Avanos Medical (AVNS), Inogen (INGN), Eargo (EAR), Sientra (SIEN), Sanara MedTech (SMTI), Conformis (CFMS), Invacare (IVC), United Health Products (UEEC), Lakeland Industries (LAKE), Alpha Pro Tech (APT), Surgalign (SRGA), Milestone Scientific (MLSS), CollPlant Biotechnologies (CLGN) and Predictive Oncology (POAI).
View all of ESTA's competitors.

What other stocks do shareholders of Establishment Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Establishment Labs investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Sientra (SIEN), Allergan (AGN), BCE (BCE), Canadian Imperial Bank of Commerce (CM), (CNDT), Canadian Natural Resources (CNQ), Chevron (CVX) and Evolus (EOLS).

When did Establishment Labs IPO?

(ESTA) raised $50 million in an IPO on Thursday, July 19th 2018. The company issued 3,100,000 shares at a price of $15.00-$17.00 per share. Jefferies and Cowen served as the underwriters for the IPO and BTIG was co-manager.

What is Establishment Labs' stock symbol?

Establishment Labs trades on the NASDAQ under the ticker symbol "ESTA."

How do I buy shares of Establishment Labs?

Shares of ESTA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Establishment Labs' stock price today?

One share of ESTA stock can currently be purchased for approximately $72.38.

How much money does Establishment Labs make?

Establishment Labs has a market capitalization of $1.71 billion and generates $84.68 million in revenue each year. The company earns $-38,120,000.00 in net income (profit) each year or ($1.55) on an earnings per share basis.

How many employees does Establishment Labs have?

Establishment Labs employs 638 workers across the globe.

What is Establishment Labs' official website?

The official website for Establishment Labs is www.establishmentlabs.com.

Where are Establishment Labs' headquarters?

Establishment Labs is headquartered at Building B15 and 25 Coyol Free Zone, Alajuela G2, .

How can I contact Establishment Labs?

Establishment Labs' mailing address is Building B15 and 25 Coyol Free Zone, Alajuela G2, . The company can be reached via phone at 506 2434 2400 or via email at [email protected]

This page was last updated on 7/27/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here